Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mr. Turley, we need three messages, not just one

oscar / Re: DDiligen

in response to by
posted on Dec 20, 2007 08:04PM
You need to inform yourself a bit more. While it's true TPL must approve PR's that PTSC issues regarding the MMP, TPL can't say anything EITHER without PTSC's approval. So it's not the evil gestapo tactics that you fear. Read the master agreement. Perhaps it will bring you some sense of calm for the season. The share price will rise as visibilty of the settlement terms come, additional licenses are signed and M&A activity heats up. Until then, take comfort that even at 63 cents, PTSC has cash in the bank that is growing as we type.
Share
New Message
Please login to post a reply